Prednisolone low

ApprovedSmall molecule

Boehringer Ingelheim

Prednisolone low is one of 55 small molecule programs targeting Inflammatory Response. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Inflammatory ResponseActive, not recruiting

AsthmaActive, not recruiting

Inflammatory ResponsePhase 1

Active, not recruiting

AsthmaApproved

Active, not recruiting

Competition

Competitive Landscape

1050 competitors in Asthma

#DrugCompanyPhaseTrials

Prednisolone low

Boehringer Ingelheim

Approved

1 2

Veramyst

GSK

Preclinical

46 3

Singulair

AstraZeneca

Preclinical

17 4

Nucala

GGlaxo Dba Glaxosmithkline

Preclinical

35 5

Dupixent

AAzienda U.S.L. 1 di Massa e Carrara

Preclinical

30 6

Asmanex

Novartis

Preclinical

5 7

Celexa

AbbVie

Preclinical

1 8

Formoterol Fumarate

AstraZeneca

Preclinical

8 9

Aciphex

Akero Therapeutics

Preclinical

2 10

Paracetamol

GSK

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Inflammatory Response1 trial

Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BI 653048 BS H3PO4 Capsule Assessing Endotoxin-induced Inflammatory Response in Healthy Male Subjects

Completed· Boehringer Ingelheim logo

Boehringer Ingelheim·Phase 1·NCT02224105·56 enrolled

Tics1 trial

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 653048 BS H3PO4 Capsule Multiple Rising Doses in Healthy Male Volunteers

Completed· Boehringer Ingelheim logo

Boehringer Ingelheim·Phase 1·NCT02217631·140 enrolled

Asthma1 trial

Oral Prednisolone Dosing in Children Hospitalized With Asthma

Completed·—·Phase 4·NCT00257933·152 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Prednisolone low. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Prednisolone low compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Prednisolone low. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Boehringer Ingelheim company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: Boehringer Ingelheim

Prednisolone low

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Inflammatory Response1 trial

Tics1 trial

Asthma1 trial

References

Drug Info

Quick Facts

Related News